Molina Healthcare Inc (MOH) has risen sharply, recording gains of 5.84% in the past 4 weeks. However, the stock has corrected -2.96% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 5.44% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
Molina Healthcare, Inc. is up 22.02% in the last 3-month period. Year-to-Date the stock performance stands at -6.64%. The stock has recorded a 20-day Moving Average of 0.44% and the 50-Day Moving Average is 5.83%.
Molina Healthcare Inc (NYSE:MOH): The stock opened at $56.16 on Friday but the bulls could not build on the opening and the stock topped out at $56.72 for the day. The stock traded down to $55.58 during the day, due to lack of any buying support eventually closed down at $56.14 with a loss of -0.09% for the day. The stock had closed at $56.19 on the previous day. The total traded volume was 359,041 shares.
Also, In a research note released to the investors, Barclays terminates its rating on Molina Healthcare Inc (NYSE:MOH).Earlier, the shares were rated a Equal-weight by the brokerage firm. The rating by the firm was issued on August 2, 2016.
Molina Healthcare, Inc. provides health care to those receiving Government assistance. The Company offers Medicaid-related solutions for low-income families and individuals, and assists state agencies in their administration of the Medicaid program. The Company operates through two segments: Health Plans segment and Molina Medicaid Solutions segment. The Companys Health Plans segment consists of health plans in around 11 states, and includes its direct delivery business. The Companys direct delivery business consists primarily of the management of a hospital in southern California, and the operation of primary care clinics in several states in which the Company operates. The Companys Molina Medicaid Solutions segment provides business processing and information technology development, and administrative services to Medicaid agencies in Idaho, Louisiana, Maine, New Jersey, West Virginia, and the United States Virgin Islands, and drug rebate administration services in Florida.